Weight loss and diabetes drug company Novo Nordisk has bought a drug manufacturing plant in Athlone as it looks to expand production to meet worldwide demand. The Danish group has paid $92.5 million ...

COPENHAGEN (Reuters) -Shares in Novo Nordisk and Eli Lilly slipped on Friday after both agreed with the U.S government to lower prices of their blockbuster GLP-1 weight-loss drugs. The deal announced ...

Novo Nordisk faces slowing semaglutide momentum as new obesity contenders, including GPCR's aleniglipron, push the ...

One of the most compelling acquisition sagas in the pharma industry in recent times has come to an end, with Pfizer prevailing over Novo Nordisk in a fierce bidding war to acquire obesity biotech ...

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind ...

(Reuters) -- Obesity drug developer Metsera has accepted Pfizer's $10 billion acquisition offer, ending a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo ...